<DOC>
	<DOCNO>NCT01138709</DOCNO>
	<brief_summary>The primary objective phase II clinical trial ass safety Vitala™ device 12 hour daily wear convex product .</brief_summary>
	<brief_title>Vitala 12 Hour Wear Test With Convex Products</brief_title>
	<detailed_description />
	<criteria>Is legal consent age . Is able read , write , understand study , require procedure , study related documentation . Has sign inform consent . Has end colostomy least 12 week duration form semiformed effluent . Currently use convex skin barrier wafer use convex insert standard skin barrier wafer willing wear SURFIT Natura® Durahesive® Skin Barrier CONVEXIT® SURFIT Natura® Disposable Convex Inserts 45mm 57mm flange size . Enrollment target 15 current convex product user 10 non convex user . The investigator relatively sure subject able wear SURFIT Natura® Durahesive® Skin Barrier CONVEXIT® 45mm 57mm flange size stoma open size 13mm 50mm SURFIT Natura® Disposable Convex Inserts 45mm 57mm flange size . Is willing remove replace skin barrier wafer three day , often desire , Stage 2 . Has stoma protrude 2 cm rest ( lie back ) . Has demonstrate success wear traditional pouching system . ( Investigator judgment ) Is willing participate trial total 43 day . Is willing meet investigator total 5 schedule visit plus additional visit deem necessary investigator . Has ability complete selfcare . Has know skin sensitivity component product test . Has skin rating `` 2 '' great accord Skin Rating Scale . Has peristomal ulceration , peristomal pressure necrosis , parastomal hernia , Caput Medusa mucocutaneous separation . Is receive radiation area pouch system . Is receive chemotherapy stable regimen maintenance chemotherapy . Requires pouch belt wear Vitala™ . Requires moldable skin barrier . Has participate clinical study within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>